Baszucki Group’s support has expanded the scope of the Cleveland Clinic Brain Study to include biomarkers from stool ...
Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesQfitlia, the first antithrombin-lowering therapy for hemophilia, ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the first patient enrollment for its phase II study investigating the efficacy and safety of nemolizumab in treating ...
Phare Bio, a biotech social venture harnessing artificial intelligence to accelerate antibiotic discovery and development, and Basilea Pharmaceutica, a commercial-stage biopharmaceutical company ...
The social media accounts of Australians aged under-16 must be deactivated, with companies facing fines for not complying.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback